跳至主要内容
临床试验/ISRCTN14657861
ISRCTN14657861进行中(未招募)不适用

Utilising QuantiFERON-CMV to personalise CMV management in haemopoietic stem cell transplant patients

Cambridge University Hospitals NHS Foundation Trust0 个研究点目标入组 60 人开始时间: 2025年12月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16 Years 至 100 Years(—)
性别
All

入选标准

  • Written informed consent form
  • Aged 16 years old or above
  • Due to undergo an allogeneic-HSCT at Cambridge University Hospitals NHS Foundation Trust Addenbrooke’s Hospital
  • Confirmed determination of donor AND recipient CMV status by serology
  • Due to take Letermovir prophylaxis following the allogeneic-HSCT
  • Willing and able to comply with scheduled visits, treatment plans, sample collections and other study procedures for the duration of the study

排除标准

  • Patient is CMV seronegative
  • Patient is in receipt of virus-specific T cell therapy

研究者

相似试验